{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T16:06:42Z","timestamp":1781280402348,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T00:00:00Z","timestamp":1771113600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology Case Reports"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.eucr.2026.103376","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T17:01:12Z","timestamp":1771261272000},"page":"103376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting mutant VHL-gene results in therapy response in metastatic clear cell carcinoma of rete testis"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7902-590X","authenticated-orcid":false,"given":"Michael Karl","family":"Melzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelika","family":"Mattigk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena I.","family":"Gaidzik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadine Therese","family":"Gaisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Schwenke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Zengerling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eucr.2026.103376_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/aja.2012.20","article-title":"Why are epididymal tumours so rare?","volume":"14","author":"Yeung","year":"2012","journal-title":"Asian J Androl"},{"key":"10.1016\/j.eucr.2026.103376_bib2","first-page":"39","article-title":"Contemporary analysis of epididymal tumors using a national database","volume":"74","author":"Bhatt","year":"2021","journal-title":"Cent European J Urol"},{"key":"10.1016\/j.eucr.2026.103376_bib3","first-page":"321","article-title":"Clear cell papillary cystadenocarcinoma of the epididymis: a case report and immunohistochemistry of markers for renal cell carcinoma","volume":"28","author":"Nozawa","year":"2013","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.eucr.2026.103376_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/01.pas.0000155160.36154.mL","article-title":"Clear cell papillary cystadenoma of the epididymis and mesosalpinx: immunohistochemical differentiation from metastatic clear cell renal cell carcinoma","volume":"29","author":"Aydin","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.eucr.2026.103376_bib5","article-title":"Paratesticular clear cell carcinoma of m\u00fcllerian origin\u2014A case report","volume":"21","author":"Warmke","year":"2020","journal-title":"Hum Pathol: Case Reports"},{"key":"10.1016\/j.eucr.2026.103376_bib6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.eucr.2026.103376_bib7","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1056\/NEJMoa2103425","article-title":"Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease","volume":"385","author":"Jonasch","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eucr.2026.103376_bib8","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1158\/1078-0432.CCR-24-1199","article-title":"FDA approval summary: Belzutifan for patients with advanced renal cell carcinoma","volume":"30","author":"Fallah","year":"2024","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.eucr.2026.103376_bib9","doi-asserted-by":"crossref","first-page":"4843","DOI":"10.1158\/1078-0432.CCR-22-1054","article-title":"FDA Approval Summary: Belzutifan for von Hippel-Lindau Disease-Associated Tumors","volume":"28","author":"Fallah","year":"2022","journal-title":"Clin Cancer Res"}],"container-title":["Urology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442026000392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214442026000392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T15:41:20Z","timestamp":1781278880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214442026000392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":9,"alternative-id":["S2214442026000392"],"URL":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103376","relation":{},"ISSN":["2214-4420"],"issn-type":[{"value":"2214-4420","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting mutant VHL-gene results in therapy response in metastatic clear cell carcinoma of rete testis","name":"articletitle","label":"Article Title"},{"value":"Urology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eucr.2026.103376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103376"}}